Dimensional Fund Advisors LP Spring Works Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$405 Billion
Q4 2024

A detailed history of Dimensional Fund Advisors LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 717,714 shares of SWTX stock, worth $36.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

717,714

Previous 725,117 1.02%

Holding current value

$36.7 Million

Previous $23.2 Million 11.62%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$28.61 - $42.55 $211,799 - $314,997	-7,403 Reduced 1.02%	717,714 $25.9 Million
Q3 2024 Nov 07, 2024	SELL	$32.04 - $42.76 $3.38 Million - $4.51 Million	-105,405 Reduced 12.69%	725,117 $23.2 Million
Q2 2024 Aug 09, 2024	SELL	$36.06 - $47.62 $2.71 Million - $3.58 Million	-75,214 Reduced 8.3%	830,522 $31.3 Million
Q1 2024 May 10, 2024	SELL	$36.5 - $52.5 $2.29 Million - $3.29 Million	-62,669 Reduced 6.47%	905,736 $44.6 Million
Q4 2023 Feb 07, 2024	SELL	$18.94 - $37.24 $813,738 - $1.6 Million	-42,964 Reduced 4.25%	968,405 $35.3 Million
Q3 2023 Nov 09, 2023	BUY	$23.12 - $31.38 $647,729 - $879,142	28,016 Added 2.85%	1,011,369 $23.4 Million
Q2 2023 Aug 09, 2023	BUY	$23.15 - $32.71 $4.35 Million - $6.15 Million	187,890 Added 23.62%	983,353 $25.8 Million
Q1 2023 May 12, 2023	BUY	$24.97 - $34.05 $13 Million - $17.8 Million	522,571 Added 191.49%	795,463 $20.5 Million
Q4 2022 Feb 09, 2023	BUY	$21.73 - $28.72 $3.93 Million - $5.2 Million	181,050 Added 197.13%	272,892 $7.1 Million
Q3 2022 Nov 10, 2022	SELL	$24.1 - $39.66 $1.47 Million - $2.43 Million	-61,158 Reduced 39.97%	91,842 $2.62 Million
Q2 2022 Aug 12, 2022	SELL	$18.36 - $60.07 $781,016 - $2.56 Million	-42,539 Reduced 21.75%	153,000 $3.77 Million
Q1 2022 May 13, 2022	BUY	$48.97 - $65.46 $161,405 - $215,756	3,296 Added 1.71%	195,539 $11 Million
Q4 2021 Feb 09, 2022	SELL	$53.3 - $75.84 $191,506 - $272,493	-3,593 Reduced 1.83%	192,243 $11.9 Million
Q3 2021 Nov 12, 2021	BUY	$62.66 - $88.26 $7.54 Million - $10.6 Million	120,323 Added 159.34%	195,836 $12.4 Million
Q2 2021 Aug 12, 2021	BUY	$67.45 - $85.63 $5.09 Million - $6.47 Million	75,513 New	75,513 $6.22 Million

Others Institutions Holding SWTX

# of Institutions

236

Shares Held

67.2M

Call Options Held

260K

Put Options Held

316K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $3.19B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Spring Works Therapeutics, Inc. Transaction History